Slowly Working Toward More Treatments for Depression in Bipolar II Disorder

Affiliations

Editorial

Michael J Ostacher. Am J Psychiatry. 2021 Dec.

. 2021 Dec;178(12):1075-1076.

doi: 10.1176/appi.ajp.2021.21101028.

¹ Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, Calif.

No abstract available

Keywords: Antipsychotics; Bipolar II Disorder; Bipolar and Related Disorders; Clinical Drug Studies.

Comment in

Treatments for Depression in Bipolar II Disorder: Reply to Durgam et al.
Ostacher M. Ostacher M. Am J Psychiatry. 2022 Sep;179(9):690. doi: 10.1176/appi.ajp.22010081r. Am J Psychiatry. 2022. PMID: 36048483 No abstract available.
Treatments for Depression in Bipolar II Disorder.
Durgam S, Chen R, Calabrese JR, Sachs GS. Durgam S, et al. Am J Psychiatry. 2022 Sep;179(9):688-690. doi: 10.1176/appi.ajp.22010081. Am J Psychiatry. 2022. PMID: 36048493 No abstract available.

Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial.
Calabrese JR, Durgam S, Satlin A, Vanover KE, Davis RE, Chen R, Kozauer SG, Mates S, Sachs GS. Calabrese JR, et al. Am J Psychiatry. 2021 Dec;178(12):1098-1106. doi: 10.1176/appi.ajp.2021.20091339. Epub 2021 Sep 23. Am J Psychiatry. 2021. PMID: 34551584 Clinical Trial.